Pharmacokinetics and pharmacodynamics of BB-10153, a thrombin-activatable plasminogen, in healthy volunteers.
Curtis, L D
Pharmacokinetics and pharmacodynamics of BB-10153, a thrombin-activatable plasminogen, in healthy volunteers. [electronic resource] - Journal of thrombosis and haemostasis : JTH Jun 2005 - 1180-6 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article
1538-7933
10.1111/j.1538-7836.2005.01352.x doi
Adolescent
Adult
Area Under Curve
Double-Blind Method
Fibrin Fibrinogen Degradation Products
Fibrinogen--drug effects
Fibrinolysis
Half-Life
Humans
Male
Pharmacokinetics
Plasminogen--administration & dosage
Thrombin--metabolism
alpha-2-Antiplasmin--drug effects
Pharmacokinetics and pharmacodynamics of BB-10153, a thrombin-activatable plasminogen, in healthy volunteers. [electronic resource] - Journal of thrombosis and haemostasis : JTH Jun 2005 - 1180-6 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article
1538-7933
10.1111/j.1538-7836.2005.01352.x doi
Adolescent
Adult
Area Under Curve
Double-Blind Method
Fibrin Fibrinogen Degradation Products
Fibrinogen--drug effects
Fibrinolysis
Half-Life
Humans
Male
Pharmacokinetics
Plasminogen--administration & dosage
Thrombin--metabolism
alpha-2-Antiplasmin--drug effects